PHAR (PHAR) Stock Price & Analysis
PHAR (PHAR) rose 0.00% to USD 12.62 as of July 26, 2026 at 08:55 UTC, according to Nexqual real-time market data.
PHAR last closed at USD 12.62; the session ranged USD 12.57–12.96 on volume of 5,089 shares. Market capitalization is —, with a 52-week range of USD 9.54–21.34 (NGM). Source: Nexqual, July 26, 2026 at 08:55 UTC.
Key Statistics (as of July 26, 2026 at 08:55 UTC)
| Price | USD 12.62 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 12.62 |
| Open | USD 12.62 |
| Day Range | USD 12.57 – 12.96 |
| 52-Week Range | USD 9.54 – 21.34 |
| Volume | 5,089 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (PHAR)
Nexqual's technical model rates PHAR "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 08:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.44 (neutral) |
| vs SMA50 | Below (USD 13.12) |
| MACD | -0.11 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHVS | Pharvaris N.V. | USD 34.17 | ▼ 0.55% |
| NBTX | Nanobiotix S.A. | USD 39.7 | ▼ 1.68% |
| PRTCY | PureTech Health PLC | USD 16.62 | ▼ 2.24% |
| SLN | Silence Therapeutics Plc - Amer | USD 11.02 | ▼ 6.85% |
| IVA | Inventiva S.A. - American Depos | USD 4.46 | ▼ 1.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 08:55 UTC. This page is informational and not investment advice.